The management of ventricular arrhythmias in the elderly - are there differences?

Dural M., GÖRENEK B.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, vol.45, pp.66-70, 2017 (ESCI, Scopus, TRDizin) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 45
  • Publication Date: 2017
  • Doi Number: 10.5543/tkda.2017.03584
  • Journal Name: TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.66-70
  • Keywords: Arrhythmia treatment, ventricular arrhythmias, elderly, IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR, CONGESTIVE-HEART-FAILURE, MYOCARDIAL-INFARCTION, SUDDEN-DEATH, AMIODARONE, AGE, POPULATION, SURVIVAL, SOTALOL, METAANALYSIS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Sudden cardiac deaths (SCD) are most often caused by ventricular arrhythmias (VA). Among all cause mortality in the elderly, the rate of SCD due to VA is decreasing. The choice of antiarrhythmic drug in elderly patients is not different according to younger patients. Treatment goals, patient compliance, drug interaction risk, liver and kidney function should be considered in the selection of antiarrhythmic drugs. ICD implantation provides mortality reduction in the elderly when appropriate patient selection is made. In older people with minimal comorbid disease and at high risk for arrhythmic death, the ICD has a higher benefit rate.